SCHEMBL7526046

SCHEMBL7526046

Cc1c(F)ccc2cc(F)ccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.44
SLC6A4 P31645 2/20 0.44
KCNH2 Q12809 2/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2A6 P11509 1/20 0.43
CA3 P07451 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
TYMS P04818 2/20 0.36
BACE1 P56817 1/20 0.35
KIF11 P52732 1/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
CASP3 P42574 1/20 0.34
AHR P35869 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20967459 0.84 CYP19A1 (0.44) CYP1A2CYP2A6CA3CA6CA5A
SCHEMBL30219728 0.79 ESR1 (0.49) CYP1A2ESR1ESR2
SCHEMBL30574198 0.79 ESR1 (0.58) SLC6A2SLC6A4KCNH2CYP1A2CYP2A6
SCHEMBL19862049 0.79 SLC6A2 (0.42) SLC6A2SLC6A4KCNH2CYP1A2CYP2A6
SCHEMBL20356018 0.77 CYP1A2 (0.46) SLC6A2SLC6A4KCNH2CYP1A2CYP2A6
SCHEMBL5252634 0.77 SLC6A2 (0.37) SLC6A2SLC6A4KCNH2CYP1A2CYP2A6
SCHEMBL12260024 0.76 CYP1A2 (0.55) SLC6A2SLC6A4KCNH2CYP1A2CYP2A6
SCHEMBL12405217 0.76 CYP1A2 (0.55) SLC6A2SLC6A4KCNH2CYP1A2CYP2A6
SCHEMBL12277510 0.76 CYP1A2 (0.55) SLC6A2SLC6A4KCNH2CYP1A2CYP2A6
SCHEMBL7666203 0.76 CYP1A2 (0.52) SLC6A2SLC6A4KCNH2CYP1A2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11251376-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-02-15 US disclosed
US-20190131535-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-05-02 US disclosed
EP-0900772-B1 Method for production of fluorine-containing aromatic compound NIPPON CATALYTIC CHEM IND (JP) 2002-04-03 EP disclosed
US-6043397-A REACTING AN AROMATIC COMPOUND HAVING CARBONYL HALIDE, ALDEHYDE OR KETONE GROUPS, AND OPTIONALLY HALOGEN GROUPS WITH A DI(ALKYL/PHENYL)AMINOSULFUR TRIFLUORIDE; REACTION CAN PROCEED IN STANDARD VESSEL AT AMBIENT TEMPERATURE, PRESSURE NIPPON SHOKUBAI CO., LTD. (JP) 2000-03-28 US disclosed
EP-0900772-A1 Method for production of fluorine-containing aromatic compound NIPPON SHOKUBAI KAGAKU KOGYO CO. LTD. (JP) 1999-03-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11251376-B2 Heterocyclic compound and organic light-emitting device including the same LAGE3, DDT, AOC2 SLC6A2 2300/4885SLC6A4 2619/4885KCNH2 178/4885
US-20190131535-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LAGE3, DDT, AOC2 SLC6A2 2300/4885SLC6A4 2619/4885KCNH2 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.